Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis.

Poder TG, Erraji J, Coulibaly LP, Koffi K.

PLoS One. 2017 May 12;12(5):e0177476. doi: 10.1371/journal.pone.0177476. eCollection 2017. Review.

2.

Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis.

Chang TI, Montez-Rath ME, Shen JI, Solomon MD, Chertow GM, Winkelmayer WC.

J Am Heart Assoc. 2014 Oct 21;3(5):e001356. doi: 10.1161/JAHA.114.001356. Erratum in: J Am Heart Assoc. 2015 Apr;4(4). pii: e000634. doi: 10.1161/JAHA.115.000634.

3.

Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry.

Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, Dai D, Kong DF, Hammill B, Curtis L, Matchar D, Brindis R, Peterson ED.

J Am Coll Cardiol. 2009 May 5;53(18):1629-41. doi: 10.1016/j.jacc.2009.03.005.

4.

Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS.

JAMA. 2008 Jun 25;299(24):2868-76. doi: 10.1001/jama.299.24.2868.

5.

Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?

Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):636-43. doi: 10.1002/ccd.21417.

6.

Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis.

Reynolds MR, Pinto DS, Shi C, Walczak J, Berezin R, Holmes DR Jr, Cohen DJ.

Am Heart J. 2007 Dec;154(6):1221-7. Epub 2007 Sep 6.

7.

Drug-eluting stent: a review and update.

Htay T, Liu MW.

Vasc Health Risk Manag. 2005;1(4):263-76. Review.

8.

Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.

Bagust A, Grayson AD, Palmer ND, Perry RA, Walley T.

Heart. 2006 Jan;92(1):68-74. Epub 2005 Apr 14.

9.
10.

The dollars and sense of drug-eluting stents.

Brophy JM.

CMAJ. 2005 Feb 1;172(3):361-2. No abstract available.

Supplemental Content

Loading ...
Support Center